DFFN

NASDAQ

Diffusion Pharmaceuticals Inc.

SectorHealth CareIndustryBiotechnology: Pharmaceutical Preparations

News25/Ratings0

Diffusion Pharmaceuticals Inc., a biopharmaceutical company, develops novel therapies that enhance the body's ability to deliver oxygen. Its lead product candidate is Trans Sodium Crocetinate that is developed to enhance the diffusion of oxygen to tissues, as well as to treat COVID-19 disease. The company is also developing DFN-529, a phosphoinositide 3-kinase/Akt/mechanistic target of rapamycin pathway inhibitor. Diffusion Pharmaceuticals Inc. was founded in 2001 and is based in Charlottesville, Virginia.

Latest news

25 items

799d13D/G
SEC Form SC 13G/A filed by Diffusion Pharmaceuticals Inc. (Amendment)
SC 13G/A - CervoMed Inc. (0001053691) (Subject)
800dINSIDER
SEC Form 4 filed by Boger Joshua S
4 - CervoMed Inc. (0001053691) (Issuer)
804d13D/G
SEC Form SC 13D filed by Diffusion Pharmaceuticals Inc.
SC 13D - CervoMed Inc. (0001053691) (Subject)
804dINSIDER
New insider Boger Joshua S claimed ownership of 561,309 shares (SEC Form 3)
3 - CervoMed Inc. (0001053691) (Issuer)
806dSEC
Diffusion Pharmaceuticals Inc. filed SEC Form 8-K: Leadership Update, Other Events, Financial Statements and Exhibits
8-K - CervoMed Inc. (0001053691) (Filer)
811dSEC
Diffusion Pharmaceuticals Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Leadership Update, Financial Statements and Exhibits
8-K - CervoMed Inc. (0001053691) (Filer)
818dINSIDER
SEC Form 4 filed by Alam John J
4 - CervoMed Inc. (0001053691) (Issuer)
818dINSIDER
SEC Form 4 filed by Blackburn Kelly
4 - CervoMed Inc. (0001053691) (Issuer)
818dINSIDER
SEC Form 4 filed by Tanner John William
4 - CervoMed Inc. (0001053691) (Issuer)
818dINSIDER
SEC Form 4 filed by Elder William Robert
4 - CervoMed Inc. (0001053691) (Issuer)
818dINSIDER
SEC Form 4 filed by Gregoire Sylvie
4 - CervoMed Inc. (0001053691) (Issuer)
818dINSIDER
SEC Form 4 filed by Cobuzzi Robert Joseph Jr.
4 - CervoMed Inc. (0001053691) (Issuer)
839dSEC
Diffusion Pharmaceuticals Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
8-K - CervoMed Inc. (0001053691) (Filer)
840dSEC
Diffusion Pharmaceuticals Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
8-K - CervoMed Inc. (0001053691) (Filer)
854dSEC
Diffusion Pharmaceuticals Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
8-K - CervoMed Inc. (0001053691) (Filer)
883dINSIDER
SEC Form 4 filed by Tanner John William
4 - CervoMed Inc. (0001053691) (Issuer)
888dSEC
Diffusion Pharmaceuticals Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Leadership Update, Financial Statements and Exhibits
8-K - CervoMed Inc. (0001053691) (Filer)
892dSEC
Diffusion Pharmaceuticals Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
8-K - CervoMed Inc. (0001053691) (Filer)
892dSEC
SEC Form 10-Q filed by Diffusion Pharmaceuticals Inc.
10-Q - CervoMed Inc. (0001053691) (Filer)
896dINSIDER
Gregoire Sylvie gifted 10,000 shares, decreasing direct ownership by 1% to 732,039 units (SEC Form 4)
4 - CervoMed Inc. (0001053691) (Issuer)
896dINSIDER
Alam John J gifted 12,500 shares, decreasing direct ownership by 2% to 729,539 units (SEC Form 4)
4 - CervoMed Inc. (0001053691) (Issuer)
897dSEC
Diffusion Pharmaceuticals Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
8-K - CervoMed Inc. (0001053691) (Filer)
905dSEC
Diffusion Pharmaceuticals Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
8-K - CervoMed Inc. (0001053691) (Filer)
911dSEC
Diffusion Pharmaceuticals Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
8-K - CervoMed Inc. (0001053691) (Filer)
933dSEC
Diffusion Pharmaceuticals Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
8-K - CervoMed Inc. (0001053691) (Filer)